--AbbVie Acquires Celsius Therapeutics in $250 Million Cash Deal-March 2024-www.financetom.com

--AbbVie Acquires Celsius Therapeutics in $250 Million Cash Deal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--AbbVie Acquires Celsius Therapeutics in $250 Million Cash Deal

Jun 27, 2024 7:07 AM

09:30 AM EDT, 06/27/2024 (MT Newswires) --

Price: 171.94, Change: +0.79, Percent Change: +0.46

Previous page： Prestige Estates expects 25% pre-sales growth in FY24 and wants to expand further in Mumbai Next page： BEML expects to receive more Vande Bharat orders and improve margin

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Prestige Estates expects 25% pre-sales growth in FY24 and wants to expand further in Mumbai

May 31, 2023

Irfan Razack, Chairman and Managing Director in an interaction with CNBC-TV18 said the company has exceeded its target of Rs 12,000 crore pre-sales in FY23 and is expecting 20 to 25 percent growth in pre-sales in FY24.

BEML expects to receive more Vande Bharat orders and improve margin

May 31, 2023

"Due to a favorable product mix of rail, metro and defence, our margins are going to be better as compared with last financial year." The company clocked the highest ever EBITDA margins of 9.3 percent in FY23.

Dixon Tech to partner with Xiaomi India for manufacturing and export of mobile phones

May 31, 2023

Dixon Technologies said that apart from manufacturing and export, it is also looking to enhance component ecosystem in India.

Arvind Fashions predicts higher cash generation as brands like Arrow continue to grow

May 31, 2023

In an interview with CNBC-TV18, Kulin Lalbhai, Vice-Chairman and Non-Executive Director of Arvind Fashions emphasized that this expansion would contribute to higher EBITDA for the company.